The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Greden, J. F.
* Articles by Chamberlin, K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Greden, J. F.
* Articles by Chamberlin, K.

Am J Psychiatry 1978; 135:963-966
Copyright © 1978 by American Psychiatric Association


REGULAR ARTICLES

Anxiety and depression associated with caffeinism among psychiatric inpatients

JF Greden, P Fontaine, M Lubetsky and K Chamberlin

Among 83 hospitalized adult psychiatric patients, 22% reported being high caffeine consumers (750 mg or more per day); these patients scored significantly greater on the State-Trait Anxiety Index and the Beck Depression Scale than moderate and low consumers. High consumers described significantly more clinical symptoms, felt that their physical health was not as good, and reported greater use of sedative- hypnotics and minor tranquilizers. Since caffeine modifies catecholamine levels, inhibits phosphodiesterase breakdown of cyclic AMP, and sensitizes receptor sites, association of caffeinism with both anxiety and depressive symptoms is possible.


This article has been cited by other articles:


Home page
Adv. Psychiatr. Treat.Home page
A. P. Winston, E. Hardwick, and N. Jaberi
Neuropsychiatric effects of caffeine
Advan. Psychiatr. Treat., November 1, 2005; 11(6): 432 - 439.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. B Patten, L. M Metz, and M. A Reimer
Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population
Multiple Sclerosis, April 1, 2000; 6(2): 115 - 120.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Evans and R. R. Griffiths
Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 285 - 294.
[Abstract] [Full Text]


Home page
ScienceHome page
B. White, C. Lincoln, N. Pearce, R Reeb, and C Vaida
Anxiety and muscle tension as consequences of caffeine withdrawal
Science, September 26, 1980; 209(4464): 1547 - 1548.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1978 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org